TBIOM logo

TBIOM

A new CPAP called AIRMONY is portable, small, light, autonomous, with multiple sensors and patented features.

2-10 employees · est. 2015 · Sant Adria De Besos, Spain

VS
ZOLL Respicardia logo

ZOLL Respicardia

Creator of the FDA approved remedē® System for the treatment of moderate to severe Central Sleep Apnea (CSA).

95 employees · est. 2006 · Minnetonka, United States

ZOLL Respicardia is the older company (2015 vs 2006); ZOLL Respicardia is the larger of the two.

Side-by-Side Comparison

TBIOM ZOLL Respicardia
Founded
2015 2006 older
Headquarters
Sant Adria De Besos, Spain Minnetonka, United States
Employees
2-10 95 larger
Industry
Biotechnology, Health Care, Medical Devices Health Care, Health and Wellness, Medical Devices
Funding Stage
Equity Crowdfunding Series Unknown
Total Funding
$408.66K $160.19M
Funding Rounds
2 9
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
CPAP Device, Sleep Apnea, Portable Medical Device, Medical Innovation, Patented Technology, Personal Health Monitor, Innovative Design, Sensor Technology, Mobile Healthcare, Autonomous Treatment, Compact Medical Device Central Sleep Apnea, FDA Approval, Implantable Stimulation Device, Respiratory Health, Sleep Disorders, Innovative Technologies, Healthcare Innovation, Neurostimulation, Acquisition, Quality Of Life, Respiratory Muscles, ZOLL Respicardia, Brain Signals
Website
yourairmony.com remede.zoll.com
TBIOM logo

About TBIOM

TBIOM AIRMONY is a revolutionary CPAP device designed for treating sleep apnea. It is portable, small, light, autonomous, and equipped with multiple sensors and patented features. Unlike conventional CPAPs, AIRMONY is tubeless, making it more practical and easy to use. The advanced design of AIRMON...

ZOLL Respicardia logo

About ZOLL Respicardia

ZOLL Respicardia is a health care startup that has gained recognition as the creator of the FDA approved remedē® System, designed to address the unmet needs of individuals suffering from moderate to severe Central Sleep Apnea (CSA). Founded in 2006 and later acquired by ZOLL in 2021, the company has...

We will tell you when either one moves

BounceWatch watches TBIOM and ZOLL Respicardia for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at TBIOM and ZOLL Respicardia — by email.

Frequently Asked Questions

TBIOM — A new CPAP called AIRMONY is portable, small, light, autonomous, with multiple sensors and patented features.. ZOLL Respicardia — Creator of the FDA approved remedē® System for the treatment of moderate to severe Central Sleep Apnea (CSA).. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
TBIOM has raised $408.66K while ZOLL Respicardia has raised $160.19M.
TBIOM and ZOLL Respicardia operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare TBIOM with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at TBIOM on 11 Sep 2024, and ZOLL Respicardia on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes